Coya Therapeutics Inc (COYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,207 | -21,226 | -15,518 | -13,402 | -7,307 |
| Depreciation Amortization | 3 | 27 | 21 | 14 | 7 |
| Accounts payable and accrued liabilities | -155 | -527 | -476 | -657 | 102 |
| Other Working Capital | -1,210 | 3,880 | 2,062 | 2,671 | 3,392 |
| Other Operating Activity | 2,360 | 7,107 | 4,179 | 2,773 | 978 |
| Operating Cash Flow | $-6,209 | $-10,739 | $-9,732 | $-8,602 | $-2,828 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -885 | -1,165 | -516 | N/A | N/A |
| Investing Cash Flow | $-885 | $-1,165 | $-516 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 10,995 | 20,387 | 38 | 19 | 19 |
| Financing Cash Flow | $10,995 | $20,387 | $38 | $19 | $19 |
| Beginning Cash Position | 46,823 | 38,340 | 38,340 | 38,340 | 38,340 |
| End Cash Position | 50,725 | 46,823 | 28,130 | 29,757 | 35,531 |
| Net Cash Flow | $3,902 | $8,483 | $-10,210 | $-8,582 | $-2,809 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,209 | -10,739 | -9,732 | -8,602 | -2,828 |
| Capital Expenditure | -885 | -1,165 | -516 | N/A | N/A |
| Free Cash Flow | -7,094 | -11,904 | -10,248 | -8,602 | -2,828 |